Pfizer
Quarterly Financials
| Values in thousands | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 |
|---|---|---|---|---|
Revenue | $17,763,000 | $17,702,000 | $13,283,000 | $14,879,000 |
Gross Profit | 11,854,000 | 11,127,000 | 8,243,000 | 10,498,000 |
EBITDA | 2,520,000 | 7,253,000 | 2,405,000 | 5,948,000 |
EBIT | 729,000 | 5,498,000 | 674,000 | 4,212,000 |
Net Income | 410,000 | 4,465,000 | 24,000 | 3,115,000 |
Net Change In Cash | 17,763,000 | 17,702,000 | 13,283,000 | 14,879,000 |
Free Cash Flow | 5,804,000 | 6,063,000 | -2,419,000 | 387,000 |
Cash | 1,043,000 | 1,092,000 | 1,052,000 | 719,000 |
Basic Shares | 5,703,000 | 5,705,000 | 5,696,000 | 5,697,000 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $63,627,000 | $58,496,000 | $100,330,000 | $81,288,000 |
Gross Profit | 45,776,000 | 28,809,000 | 65,986,000 | 50,467,000 |
EBITDA | 11,114,000 | 9,557,000 | 41,031,000 | 30,793,000 |
EBIT | 14,938,000 | 3,267,000 | 35,967,000 | 25,602,000 |
Net Income | 8,031,000 | 2,119,000 | 31,372,000 | 21,979,000 |
Net Change In Cash | 63,627,000 | 58,496,000 | 100,330,000 | 81,288,000 |
Cost of Revenue | -1,350,000 | 218,000 | ||
Free Cash Flow | 9,835,000 | 4,793,000 | 26,031,000 | 29,869,000 |
Cash | 1,043,000 | 2,853,000 | 416,000 | 1,944,000 |
Basic Shares | 5,700,000 | 5,709,000 | 5,733,000 | 5,708,000 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-12-31 | $0.63 |
2024-09-30 | $1.06 |
2024-06-30 | $0.60 |
2024-03-31 | $0.82 |
